Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

460
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Angina IV: Management01:26

Angina IV: Management

328
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis.

Obesity science & practice·2026
Same author

GLP-1 and Nutrient Stimulated Hormone Targets: Beyond Weight Loss.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

TOS/OMA/OAC Expert Guidance Statement on Obesity Pharmacotherapy: A Humbling Call to Action.

Obesity (Silver Spring, Md.)·2026
Same author

Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023.

Diabetes & metabolism journal·2026
Same author

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.

JAMA cardiology·2025
Same author

Once-Monthly Maridebart Cafraglutide in Obesity - A Phase 2 Trial. Reply.

The New England journal of medicine·2025

Related Experiment Video

Updated: Feb 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Guideline Recommendations for Obesity Management.

Donna H Ryan1, Scott Kahan2

  • 1Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70130, USA.

The Medical Clinics of North America
|November 21, 2017
PubMed
Summary

Healthcare providers must manage obesity. This review compares key obesity guidelines from major societies, highlighting agreements and disagreements to aid primary care practices in applying evidence-based recommendations.

Keywords:
Bariatric surgeryDietLifestyle interventionMedicationObesity guidelinesObesity pharmacotherapyWeight management

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.6K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.9K

Related Experiment Videos

Last Updated: Feb 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.6K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.9K

Area of Science:

  • Endocrinology
  • Public Health
  • Clinical Practice Guidelines

Background:

  • Obesity is a complex chronic disease requiring active management by healthcare providers.
  • Multiple professional organizations have developed guidelines for obesity management.
  • Primary care settings are crucial for implementing effective obesity interventions.

Purpose of the Study:

  • To review and compare current obesity management guidelines from The Obesity Society, the Endocrine Society, and the American Association of Clinical Endocrinologists.
  • To identify areas of consensus and divergence among major obesity guidelines.
  • To provide practical recommendations for primary care practices to utilize these guidelines.

Main Methods:

  • Comparative analysis of published obesity management guidelines.
  • Literature review of recommendations from The Obesity Society, the Endocrine Society, and the American Association of Clinical Endocrinologists.
  • Synthesis of findings to identify concordance and controversy.

Main Results:

  • Guidelines show general agreement on the chronic nature of obesity and the need for comprehensive management.
  • Specific recommendations regarding pharmacotherapy, surgical interventions, and behavioral support vary across guidelines.
  • Areas of controversy include the thresholds for initiating certain treatments and the emphasis on specific therapeutic modalities.

Conclusions:

  • Healthcare providers have an obligation to actively participate in obesity management.
  • Understanding the nuances and differences between major obesity guidelines is essential for tailored patient care.
  • Primary care practices can leverage this comparative analysis to integrate appropriate, evidence-based obesity management strategies into their workflows.